Market Brief
Compare MarketsSide-by-side comparison across 2-6 markets.Top 5 MarketsRank the best-fit markets for your product by score.Global Value DossierHTA pathways, pricing corridors, and evidence requirements by market.Pricing & Evidence SimulatorModel conservative, base, and optimistic reimbursement outcomes across markets.Scenario PlannerPESTLE risk scan and named scenarios: plan now or monitor.Regulatory TrackerMonitor regulatory and market changes across your target markets, alerts at your chosen frequency.
MatchEnterprisePricingBook a call
Get Started

From market question to market execution.

AI-native market entry platform for pharma, biotech, and medtech teams, across 90 markets including all 50 US states.

Generate your brief. It takes 2 minutes. →Request a demo
MARKET BRIEF 🇻🇳
›
COMPARE 🇧🇷🇨🇴🇲🇽
›
TOP 5 🌏
›
GVD 🇮🇩
›
PRICING 🇨🇱
›
REG TRACKER 🇵🇭
MARKET BRIEF
MARKET BRIEF
Vietnam · GLP-1 Receptor Agonist
DECISIONEnter with conditions: BHYT formulary listing required; 18-24 month access timeline.
90
Markets covered
Cited
To primary sources
$20-40K
Replaced
20+
Authorities, named
The full workflow, one product
Eight tools. One clear decision.
A medical device entering Indonesia. Each tool answers one question, and hands the next its answer.
01 · Map, learn the market
02 · Decide, weigh the move
03 · Execute, make it happen
MARKET BRIEF✓ cited to source
Asks: can we legally sell here at all?
Yes, but no shortcut. Approval takes 6 to 9 months and a local partner must own the licence.
Your US and EU clearances help but do not fast-track you. Indonesia's regulator (BPOM) runs a full review, and only a licensed local distributor can hold the registration.
US/EU clearanceHelps, not enough
Approval time6 to 9 months
Who holds licenceLocal distributor
↓If it takes that long, is Indonesia even worth doing first? Rank it against everywhere else.
↓ EIGHT ANSWERS, ONE DECISION
Enter the Philippines first. Run Indonesia in parallel, sell through private hospitals, and plan for 10 to 15 months. Watch the local-content rule closely.
Every step above is real Vantro output. Run it for your market.
Pricing

Simple, transparent pricing.

Start free. Upgrade when you're ready.

Free
$0
No card required
  • —3 market briefs
  • —All 6 entry dimensions
  • —Risk flags included
  • —No PDF export
Start free →
Pro
Most popular
$399
per month
  • —Unlimited briefs (Quick + Full)
  • —Compare Markets
  • —Global Value Dossier
  • —Pricing & Evidence Simulator
  • —Regulatory Tracker
  • —PDF export · 3 team seats
Enterprise
Custom
Tailored to your team
  • —Everything in Pro
  • —Vantro Match (expert connections)
  • —Market entry advisory
  • —Unlimited team seats · Quarterly check-ins
Contact us →

All market briefs are cited to primary sources including WHO, World Bank, national regulatory authorities, and UNICEF Supply Division.

Contact us.

Whether you have a specific market question, want to book a call, or are interested in a subscription, drop us a message.

Or
Book a call →

30 minutes. We'll walk you through the platform and answer any questions about your specific markets and product type.